Literature DB >> 27587203

Emerging Role of G-quadruplex DNA as Target in Anticancer Therapy.

Graziella Cimino-Reale, Nadia Zaffaroni, Marco Folini1.   

Abstract

DNA has represented the most exploited target for the development of anticancer agents. It is now established that DNA may assume a variety of non-B conformations. This evidence has generated a total novel wave of interest in DNA as a cancer-associated target, since its distinct non-B structures may be regarded as sites for selective therapeutic intervention. G-quadruplexes are peculiar non-B DNA conformations that may form within guaninerich nucleic acid sequences. They are generated by a core of two or more vertically stacked G-quartets (i.e., the square planar arrangement of four guanine residues) held together by intervening loops of variable length. The evidence that G-quadruplexes are highly polymorphic and overrepresented within human genome points out at such non-B DNA conformations as druggable sites amenable of targeting by small molecules. In the present paper we will provide a concise overview on the emerging role of G-quadruplex structures forming within telomeres, gene promoters and mitochondrial DNA as a promising therapeutic target in cancer. In this context, a variety of small molecules has been documented to have excellent G-quadruplex binding/stabilizing properties and to exert good antiproliferative and antitumor activity in several in vitro and in vivo models of human cancers. Pieces of evidence indicate that targeting G-quadruplexes may represent an innovative and fascinating approach for the therapeutic management of the neoplastic disease. However, several issues still need to be addressed both at chemical and biological level before G-quadruplex-interacting molecules will turn out into effective therapeutic agents. Nevertheless, this has been an exciting, though sometime subdued, field of research over the last century. The continued improvements in methodologies and the development of specific tools will contribute not only to achieve the design and development of potentially novel anticancer approaches but also to deepen our knowledge of G-quadruplex biology and, consequently, of cancer at molecular level. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  G-quadruplex; Gene promoter; mitochondrial DNA; non-B DNA; telomeres.

Mesh:

Substances:

Year:  2016        PMID: 27587203     DOI: 10.2174/1381612822666160831101031

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  25 in total

1.  DNA damage and genome instability by G-quadruplex ligands are mediated by R loops in human cancer cells.

Authors:  Alessio De Magis; Stefano G Manzo; Marco Russo; Jessica Marinello; Rita Morigi; Olivier Sordet; Giovanni Capranico
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-27       Impact factor: 11.205

2.  Regulation of autophagy by DNA G-quadruplexes.

Authors:  Pauline Lejault; Jose F Moruno-Manchon; Sree M Vemu; Pedram Honarpisheh; Liang Zhu; Nayun Kim; Akihiko Urayama; David Monchaud; Louise D McCullough; Andrey S Tsvetkov
Journal:  Autophagy       Date:  2020-06-10       Impact factor: 16.016

3.  Polarizable Molecular Dynamics Simulations of Two c-kit Oncogene Promoter G-Quadruplexes: Effect of Primary and Secondary Structure on Loop and Ion Sampling.

Authors:  Alexa M Salsbury; Tanner J Dean; Justin A Lemkul
Journal:  J Chem Theory Comput       Date:  2020-04-30       Impact factor: 6.006

4.  Naphthalene Diimides Carrying Two β-Cyclodextrins Prefer Telomere RNA G-Quadruplex Recognition.

Authors:  Tingting Zou; Yuka Sato; Shuma Kaneyoshi; Kota Mano; Rui Yasukawa; Yoshifumi Nakano; Satoshi Fujii; Shinobu Sato; Shigeori Takenaka
Journal:  Molecules       Date:  2022-06-23       Impact factor: 4.927

5.  G-quadruplex ligands mediate downregulation of DUX4 expression.

Authors:  Lukasz Ciszewski; Ngoc Lu-Nguyen; Alex Slater; Andrew Brennan; Huw E L Williams; George Dickson; Mark S Searle; Linda Popplewell
Journal:  Nucleic Acids Res       Date:  2020-05-07       Impact factor: 16.971

Review 6.  Modulation of DNA structure formation using small molecules.

Authors:  Imee M A Del Mundo; Karen M Vasquez; Guliang Wang
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2019-09-03       Impact factor: 4.739

7.  Cysteine-rich protein 61 regulates the chemosensitivity of chronic myeloid leukemia to imatinib mesylate through the nuclear factor kappa B/Bcl-2 pathway.

Authors:  Yanfang Song; Qing Lin; Zhaolian Cai; Taisen Hao; Yaohan Zhang; Xianjin Zhu
Journal:  Cancer Sci       Date:  2019-06-18       Impact factor: 6.716

8.  Quinazoline Ligands Induce Cancer Cell Death through Selective STAT3 Inhibition and G-Quadruplex Stabilization.

Authors:  Jan Jamroskovic; Mara Doimo; Karam Chand; Ikenna Obi; Rajendra Kumar; Kristoffer Brännström; Mattias Hedenström; Rabindra Nath Das; Almaz Akhunzianov; Marco Deiana; Kazutoshi Kasho; Sebastian Sulis Sato; Parham L Pourbozorgi; James E Mason; Paolo Medini; Daniel Öhlund; Sjoerd Wanrooij; Erik Chorell; Nasim Sabouri
Journal:  J Am Chem Soc       Date:  2020-01-28       Impact factor: 15.419

Review 9.  Exploiting Replication Stress as a Novel Therapeutic Intervention.

Authors:  Jeffrey C Martin; Tamara J Hoegel; Miranda L Lynch; Anna Woloszynska; Thomas Melendy; Joyce E Ohm
Journal:  Mol Cancer Res       Date:  2020-10-05       Impact factor: 6.333

Review 10.  How 'Protein-Docking' Translates into the New Emerging Field of Docking Small Molecules to Nucleic Acids?

Authors:  Francesca Tessaro; Leonardo Scapozza
Journal:  Molecules       Date:  2020-06-13       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.